Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Respirology ; 24(5): 453-458, 2019 05.
Article in English | MEDLINE | ID: mdl-30675961

ABSTRACT

BACKGROUND AND OBJECTIVE: Percutaneous lung biopsy for diagnostic sampling of peripheral lung nodules has been widely performed by interventional radiologists under computed tomography (CT) guidance. New technology allows pulmonologists to perform percutaneous lung biopsies using electromagnetic (EM) guided technology. With the adoption of this new technique, the safety, feasibility and diagnostic yield need to be explored. The goal of this study was to determine the safety, feasibility and diagnostic yield of EM-guided percutaneous lung biopsy performed by pulmonologists. METHODS: We conducted a retrospective, multicentre study of 129 EM-guided percutaneous lung biopsies that occurred between November 2013 and March 2017. The study consisted of seven academic and three community medical centres. RESULTS: The average age of participants was 65.6 years, BMI was 26.3 and 50.4% were females. The majority of lesions were in the right upper lobe (37.2%) and left upper lobe (31.8%). The mean size of the lesions was 27.31 mm and the average distance from the pleura was 13.2 mm. Practitioners averaged two fine-needle aspirates and five core biopsies per procedure. There were 23 (17.8%) pneumothoraces, of which 16 (12.4%) received small-bore chest tube placement. The diagnostic yield of percutaneous lung biopsy was 73.7%. When EM-guided bronchoscopic sampling was also performed during the same procedural encounter, the overall diagnostic yield increased to 81.1%. CONCLUSION: In this large multicentred series, the use of EM guidance for percutaneous lung biopsies was safe and feasible, with acceptable diagnostic yield in the hands of pulmonologists. A prospective multicentre trial to validate these findings is currently underway (NCT03338049).


Subject(s)
Biopsy/methods , Lung Neoplasms/pathology , Multiple Pulmonary Nodules/pathology , Pulmonary Medicine/methods , Adult , Aged , Aged, 80 and over , Biopsy/adverse effects , Biopsy, Fine-Needle/adverse effects , Biopsy, Large-Core Needle/adverse effects , Bronchoscopy , Electromagnetic Phenomena , Feasibility Studies , Female , Humans , Image-Guided Biopsy/adverse effects , Lung/pathology , Lung Neoplasms/diagnosis , Male , Middle Aged , Multiple Pulmonary Nodules/diagnosis , Pneumothorax/etiology , Retrospective Studies
2.
J Cyst Fibros ; 16(4): 499-502, 2017 Jul.
Article in English | MEDLINE | ID: mdl-27979723

ABSTRACT

BACKGROUND: Pleural effusions are considered rare in cystic fibrosis (CF) patients. There is a paucity of available information in the literature concerning the nature and significance of pleural effusions in non-transplanted CF patients. METHODS: We conducted a multicenter retrospective evaluation of non-transplanted adult CF patients. Given the small sample size, only descriptive statistics were performed. RESULTS: A total of 17 CF patients with pleural effusion were identified, of whom 9 patients underwent thoracentesis. The crude incidence of pleural effusion was 43 per 10,000 person-years in hospitalized CF patients at large CF centers. All sampled effusions were inflammatory in nature. All samples submitted for culture grew at least one organism. CONCLUSION: Pleural effusions are rare in adult non-transplanted CF patients. These fluid collections appear to be quite inflammatory with a higher rate of empyema than in the general population.


Subject(s)
Cystic Fibrosis/complications , Pleural Effusion , Thoracentesis , Adult , Exudates and Transudates , Female , Humans , Incidence , Male , Patient Outcome Assessment , Pleural Effusion/diagnosis , Pleural Effusion/epidemiology , Pleural Effusion/etiology , Pleural Effusion/therapy , Retrospective Studies , Thoracentesis/methods , Thoracentesis/statistics & numerical data , United States/epidemiology
3.
Respir Care ; 60(3): e46-8, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25336533

ABSTRACT

The development of a persistent air leak after pneumothorax can be encountered in patients with underlying structural lung disease. In those with advanced malignancy or other comorbidities, the ability to tolerate general anesthesia and thoracoscopic procedures may limit definitive management. We describe the case of a 68-y-old male with refractory acute myelogenous leukemia presenting with recurrent secondary spontaneous pneumothorax and persistent air leak related to an underlying fungal pneumonia. Endobronchial valve placement allowed for timely chest tube removal and discharge from the hospital, as well as avoidance of a thoracoscopic procedure and pleurodesis.


Subject(s)
Bronchi/surgery , Bronchoscopy/methods , Lung Neoplasms/complications , Pneumothorax/surgery , Prostheses and Implants , Humans , Lung Neoplasms/diagnosis , Male , Pneumothorax/diagnosis , Pneumothorax/etiology , Recurrence , Tomography, X-Ray Computed
SELECTION OF CITATIONS
SEARCH DETAIL
...